Literature DB >> 20068453

Estrogen is renoprotective via a nonreceptor-dependent mechanism after cardiac arrest in vivo.

Michael P Hutchens1, Takaaki Nakano, Yasuharu Kosaka, Jennifer Dunlap, Wenri Zhang, Paco S Herson, Stephanie J Murphy, Sharon Anderson, Patricia D Hurn.   

Abstract

BACKGROUND: Severe ischemia induces renal injury less frequently in women than men. In this study, cardiac arrest and cardiopulmonary resuscitation were used to assess whether estradiol is renoprotective via an estrogen receptor (ER)-dependent mechanism.
MATERIALS AND METHODS: Male and female C57BL/6 and ER gene-deleted mice underwent 10 min of cardiac arrest followed by cardiopulmonary resuscitation. Serum chemistries and renal stereology were measured 24 h after arrest.
RESULTS: Estrogen did not affect mean arterial pressure, regional renal cortical blood flow, and arterial blood gases. Hence, female kidneys were protected (mean +/- SEM: blood urea nitrogen, 65+/- 21 vs.149+/- 27 mg/dl, P = 0.04; creatinine, 0.14 +/- 0.05 vs. 0.73 +/- 0.16 mg/dl, P = 0.01; volume of necrotic tubules, 7 +/- 1% vs. 10 +/- 0%, P = 0.04). Estrogen also reduced renal injury. In intact females (n = 5), ovariectomized/vehicle-treated (n = 8), and ovariectomized/estrogen-treated (n = 8) animals, blood urea nitrogen was 65 +/- 21, 166 +/- 28, and 50 +/- 14 mg/dl (P = 0.002); creatinine was 0.14 +/- 0.05, 0.74 +/- 0.26, and 0.23 +/- 0.27 mg/dl (P = 0.014); necrotic tubules were 2.5 +/- 0.25%, 12.0 +/- 1.9%, and 5.0 +/- 1.6% (P = 0.004), respectively. In ER-[alpha] and ER-[beta] gene-deleted mice and controls estradiol-reduced functional injury (blood urea nitrogen: estradiol 117 +/- 71, vehicle 167 +/- 56, P = 0.007; creatinine: estradiol 0.5 +/- 0.5, vehicle 1.0 +/- 0.4, P = 0.013), but the effect of estradiol was not different between ER-[alpha] or ER-[beta] gene-deleted mice. Adding ICI 182,780 to estradiol did not alter injury.
CONCLUSIONS: In women, kidneys were protected from cardiac arrest through estrogen. Estradiol-mediated renoprotection was not affected by ER deletion or blockade. Estradiol is renoprotective after cardiac arrest. The results indicate that estradiol renoprotection is ER-[alpha] and ER-[beta] independent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068453      PMCID: PMC2821813          DOI: 10.1097/ALN.0b013e3181c98da9

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  64 in total

Review 1.  Stereologic methods and their application in kidney research.

Authors:  J R Nyengaard
Journal:  J Am Soc Nephrol       Date:  1999-05       Impact factor: 10.121

2.  Differential gender differences in ischemic and nephrotoxic acute renal failure.

Authors:  Qingqing Wei; Mong-Heng Wang; Zheng Dong
Journal:  Am J Nephrol       Date:  2005-09-06       Impact factor: 3.754

3.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta.

Authors:  J H Krege; J B Hodgin; J F Couse; E Enmark; M Warner; J F Mahler; M Sar; K S Korach; J A Gustafsson; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Dose-dependent neuroprotection by 17beta-estradiol after cardiac arrest and cardiopulmonary resuscitation.

Authors:  Ruediger R Noppens; Julia Kofler; Patricia D Hurn; Richard J Traystman
Journal:  Crit Care Med       Date:  2005-07       Impact factor: 7.598

5.  Involvement of nitric oxide in the suppressive effect of 17beta-estradiol on endothelin-1 overproduction in ischemic acute renal failure.

Authors:  Yujiro Shibata; Masanori Takaoka; Daisuke Maekawa; Chika Kuwahara; Yasuo Matsumura
Journal:  J Cardiovasc Pharmacol       Date:  2004-11       Impact factor: 3.105

Review 6.  Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury.

Authors:  Ajay Kher; Kirstan K Meldrum; Meijing Wang; Ben M Tsai; Jeffrey M Pitcher; Daniel R Meldrum
Journal:  Cardiovasc Res       Date:  2005-09-01       Impact factor: 10.787

7.  17beta-estradiol differentially activates mitogen-activated protein-kinases and improves survival following reperfusion injury of reduced-size liver in mice.

Authors:  M Vilatoba; C Eckstein; G Bilbao; L Frennete; D E Eckhoff; J L Contreras
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

8.  Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model.

Authors:  Agnieszka A Ardelt; Louise D McCullough; Kenneth S Korach; Michael M Wang; Diane H Munzenmaier; Patricia D Hurn
Journal:  Stroke       Date:  2005-01-06       Impact factor: 7.914

9.  Non-dialysis-dependent renal dysfunction and cardiac surgery-an assessment of perioperative risk factors.

Authors:  Gopal C Kowdley; Shishir Maithal; Shafqat Ahmed; David Naftel; Robert Karp
Journal:  Curr Surg       Date:  2005 Jan-Feb

10.  Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury.

Authors:  Kwon Moo Park; Jee In Kim; Youngkeun Ahn; Andrew J Bonventre; Joseph V Bonventre
Journal:  J Biol Chem       Date:  2004-09-08       Impact factor: 5.157

View more
  33 in total

1.  Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.

Authors:  Mingjun Shi; Brianna Flores; Peng Li; Nancy Gillings; Kathryn L McMillan; Jianfeng Ye; Lily Jun-Shen Huang; Sachdev S Sidhu; Yong-Ping Zhong; Maria T Grompe; Philip R Streeter; Orson W Moe; Ming Chang Hu
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

Review 2.  Renoprotective approaches and strategies in acute kidney injury.

Authors:  Yuan Yang; Meifang Song; Yu Liu; Hong Liu; Lin Sun; Youming Peng; Fuyou Liu; Manjeri A Venkatachalam; Zheng Dong
Journal:  Pharmacol Ther       Date:  2016-04-22       Impact factor: 12.310

Review 3.  What have we learned about GPER function in physiology and disease from knockout mice?

Authors:  Eric R Prossnitz; Helen J Hathaway
Journal:  J Steroid Biochem Mol Biol       Date:  2015-07-16       Impact factor: 4.292

4.  Determination of renal function and injury using near-infrared fluorimetry in experimental cardiorenal syndrome.

Authors:  Mizuko Ikeda; Rumie Wakasaki; Katie J Schenning; Thomas Swide; Jeong Heon Lee; M Bernie Miller; Hak Soo Choi; Sharon Anderson; Michael P Hutchens
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-11

5.  Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo.

Authors:  Michael P Hutchens; Tetsuhiro Fujiyoshi; Radko Komers; Paco S Herson; Sharon Anderson
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

6.  Extracranial hypothermia during cardiac arrest and cardiopulmonary resuscitation is neuroprotective in vivo.

Authors:  Michael P Hutchens; Tetsuhiro Fujiyoshi; Ines P Koerner; Paco S Herson
Journal:  Ther Hypothermia Temp Manag       Date:  2014-05-27       Impact factor: 1.286

7.  Improved renal ischemia tolerance in females influences kidney transplantation outcomes.

Authors:  David D Aufhauser; Zhonglin Wang; Douglas R Murken; Tricia R Bhatti; Yanfeng Wang; Guanghui Ge; Robert R Redfield; Peter L Abt; Liqing Wang; Nikolaos Svoronos; Arwin Thomasson; Peter P Reese; Wayne W Hancock; Matthew H Levine
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

Review 8.  GPER-novel membrane oestrogen receptor.

Authors:  Margaret A Zimmerman; Rebecca A Budish; Shreya Kashyap; Sarah H Lindsey
Journal:  Clin Sci (Lond)       Date:  2016-06-01       Impact factor: 6.124

9.  GPER1/GPR30 activation improves neuronal survival following global cerebral ischemia induced by cardiac arrest in mice.

Authors:  Y Kosaka; N Quillinan; Ct Bond; Rj Traystman; Pd Hurn; Ps Herson
Journal:  Transl Stroke Res       Date:  2012-09-12       Impact factor: 6.829

10.  Females of childbearing age have a survival benefit after out-of-hospital cardiac arrest.

Authors:  M Austin Johnson; Jason S Haukoos; Todd M Larabee; Stacie Daugherty; Paul S Chan; Bryan McNally; Comilla Sasson
Journal:  Resuscitation       Date:  2012-09-15       Impact factor: 5.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.